EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatitis C (HCV) Reinfection and Risk Factors among Clients of a Low-Threshold Primary Healthcare Service for People Who Inject Drugs in Sydney, Australia

Phillip Read iD, Bruce Zi Huan Tang, Edmund Silins, Anna Doab, Vincent J Cornelisse iD, Rosie Gilliver

Viruses · 2024

DOI: 10.3390/v16060957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Phillip Read und 5 weiteren Autor:innen. Beteiligte Einrichtung: Kirketon Road Centre, Kings Cross, P.O. Box 22, Sydney, NSW 1340, Australia. Hauptthemen laut MEDLINE: Hepatitis C, Primary Health Care, Substance Abuse, Intravenous, Reinfection. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C (HCV) reinfection studies have not focused on primary healthcare services in Australia, where priority populations including people who inject drugs (PWID) typically engage in healthcare. We aimed to describe the incidence of HCV reinfection and associated risk factors in a cohort of people most at risk of reinfection in a real-world community setting. We conducted a secondary analysis of routinely collected HCV testing and treatment data from treatment episodes initiated with direct-acting antiviral (DAA) therapy between October 2015 and June 2021. The overall proportion of clients (N = 413) reinfected was 9% (N = 37), and the overall incidence rate of HCV reinfection was 9.5/100PY (95% CI: 6.3–14.3). Reinfection incidence rates varied by sub-group and were highest for Aboriginal and/or Torres Strait Islander people (20.4/100PY; 95% CI: 12.1–34.4). Among PWID (N= 321), only Aboriginality was significantly associated with reinfection (AOR: 2.73, 95% CI: 1.33–5.60, p = 0.006). High rates of HCV reinfection in populations with multiple vulnerabilities and continued drug use, especially among Aboriginal and Torres Strait Islander people, highlight the need for ongoing regular HCV testing and retreatment in order to achieve HCV elimination. A priority is resourcing testing and treatment for Aboriginal and/or Torres Strait Islander people. Our findings support the need for novel and holistic healthcare strategies for PWID and the upscaling of Indigenous cultural approaches and interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CPrimary Health CareSubstance Abuse, IntravenousReinfectionAdultHepacivirusFemaleHumansAustralasian PeopleMiddle AgedMaleYoung AdultAustraliaAntiviral AgentsRisk FactorsAustralian Aboriginal and Torres Strait Islander PeoplesIncidence

Stichwörter der Autor:innen

hepatitis Cprimary healthcarereinfectionrisk factorsvulnerable populations

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Kirketon Road Centre, Kings Cross, P.O. Box 22, Sydney, NSW 1340, Australia.
  • Kirby Institute, UNSW Australia, Sydney, NSW 2032, Australia.
  • UNSW Medicine and Health, Sydney, NSW 2052, Australia.
  • National Drug and Alcohol Research Centre (NDARC), UNSW Australia, Sydney, NSW 2052, Australia.

ORCID-Profile: Phillip Read, Vincent J Cornelisse

Zitieren

APA

Read, P., Tang, B. Z. H., Silins, E., Doab, A., Cornelisse, V. J., & Gilliver, R. (2024). Hepatitis C (HCV) Reinfection and Risk Factors among Clients of a Low-Threshold Primary Healthcare Service for People Who Inject Drugs in Sydney, Australia. Viruses. https://doi.org/10.3390/v16060957

Vancouver

Read P, Tang BZH, Silins E, Doab A, Cornelisse VJ, Gilliver R. Hepatitis C (HCV) Reinfection and Risk Factors among Clients of a Low-Threshold Primary Healthcare Service for People Who Inject Drugs in Sydney, Australia. Viruses. 2024. doi:10.3390/v16060957

BibTeX
@article{Read2024,
  author = {Read, Phillip and Tang, Bruce Zi Huan and Silins, Edmund and Doab, Anna and Cornelisse, Vincent J and Gilliver, Rosie},
  title = {Hepatitis C (HCV) Reinfection and Risk Factors among Clients of a Low-Threshold Primary Healthcare Service for People Who Inject Drugs in Sydney, Australia},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16060957}
}
Kostenlos starten →